Fig. 2.

Circulating Plasma levels of sACE2 in COVID-19 groups. (A) Plasma levels of sACE2 in all COVID-19 cases. (B) Plasma levels of sACE2 in severe COVID-19 cases. (C) Plasma levels of sACE2 in moderate COVID-19 cases. (D) Plasma levels of sACE2 between severe and moderate COVID-19 group. The results are expressed in median (IQR). Wilcoxon Signed Rank Test and Mann-Whitney U Test were used to compare data within the groups and between groups, respectively. P-value ≤ 0.05 is considered significant.

∗Indicates the P ≤ 0.05; ∗∗ Indicates the P ≤ 0.01; ∗∗∗ Indicates the P ≤ 0.001.